Rationale: Peripheral muscle alterations have been recognized to contribute to disability in chronic obstructive pulmonary disease (COPD). Objectives: To describe the mitochondrial phenotype in a moderate to severe COPD population and age-matched controls. Methods: Three primary aspects of mitochondrial function were assessed in permeabilized locomotor muscle fibers. Measurements and Main Results: Respiration rates per milligram of fiber weight were significantly lower in COPD muscle compared with healthy age-matched control muscle under various respiratory states. However, when variations in mitochondrial volume were taken into account by normalizing respiration per unit of citrate synthase activity, differences between the two groups were abolished, suggesting the absence of specific mitochondrial respiratory impairment in COPD. H 2 O 2 production per mitochondrion was higher both under basal and ADP-stimulated states, suggesting that mitochondria from COPD muscle have properties that potentiate H 2 O 2 release. Direct assessment of mitochondrial sensitivity to Ca 21 -induced opening of the permeability transition pore (PTP) indicated that mitochondria from patients with COPD were more resistant to PTP opening than their counterparts in control subjects. Conclusions: Comparison of these results with those of studies comparing healthy glycolytic with oxidative muscle suggests that these differences may be attributable to greater type II fiber expression in COPD muscle, as mitochondria within this fiber type have respiratory function similar to that of mitochondria from type I fibers, and yet are intrinsically prone to greater release of H 2 O 2 and more resistant to PTP opening. These results thus argue against the presence of pathological mitochondrial alterations in this category of patients with COPD.
Peripheral muscle alterations are now recognized as an important contributor to exercise intolerance, reduced quality of life, and ultimately to disability and poor outcome in patients with chronic obstructive pulmonary disease (COPD) (1) . These alterations, which include muscle fiber atrophy, lower proportion of type I fibers, reduced muscle capillarization, and reduced oxidative capacity (2, 3) , have been largely attributed to muscle inactivity associated with disuse in the context of consequences of a sedentary lifestyle. However, given the severity of these changes relative to those observed in sedentary but otherwise healthy individuals, it has been suggested that reduced muscle activity may not be the only underlying factor (4, 5) . In support of this notion, studies have shown that locomotor skeletal muscle from patients with COPD can display signs of oxidative stress (6) , activation of proteolytic pathways (7) , and enhanced apoptosis (8) . Together, these observations have led to the proposal that an intrinsic muscle disease (i.e., a myopathic state) could play an additional role in atrophy, weakness (4) , and overall exercise intolerance. However, evidence of muscle dysfunction, or the period of disease progression at which this myopathic state could become a significant contributor to dysfunction, is still lacking; moreover, the putative mechanisms involved in its development remain unknown.
Maintenance of mitochondrial integrity is crucial to the preservation of cellular energy homeostasis. The role of mitochondria also extends far beyond energy production, as they constitute important generators of reactive oxygen species (ROS) that can act either as second messengers or as a source of cellular damage depending on the amount being produced (9) . In addition, it is now well established that in response to specific signals or after internal damage to mitochondria, these organelles have the capacity to activate necrosis and apoptosis by increasing their membrane permeability, through opening of the permeability transition pore (PTP) (10) . Therefore, it is increasingly being proposed that, in addition to the potential contribution of steroid-induced toxicity from corticosteroid treatments (11) , chronic low-grade systemic inflammation (12) , and/or hypoxemia (13) , the development of specific mitochondrial abnor-malities could be an integral part of muscle disease in patients with COPD (4) . However, direct experimental evidence in support of this notion is currently lacking.
In the present study, we used permeabilized muscle fibers taken from the quadriceps of healthy control individuals and patients with COPD to perform an integrative analysis of mitochondrial function. Respiratory function was determined in different states of activity in the presence of substrates and inhibitors for various respiratory chain complexes. In addition, we used novel approaches developed in our laboratory (14) to provide the first direct assessment of mitochondrial ROS production and sensitivity to PTP opening in human muscles fibers. We hypothesized that in addition to a reduced amount of mitochondria (15, 16) caused by adoption of a sedentary lifestyle, muscle from patients would display signs of specific mitochondrial abnormalities such as impairment of respiratory responses, increased production of ROS, and vulnerability to opening of the PTP in response to a Ca 21 challenge, a typical trigger of permeability transition. Some results of this study have been previously reported in abstract form (17) .
METHODS

Study Participants
Seven male patients with COPD based on the Global Initiative for Chronic Obstructive Lung Disease classification of disease severity (18) (FEV 1 5 1.32 6 0.2 L; 47 6 6% predicted) and eight healthy male sedentary control subjects matched for age (65 yr) were investigated. See the online supplement for inclusion criteria. The study was approved by the ethics review board of the Montreal Chest Institute (Montréal, PQ, Canada), and all participants provided written informed consent. All study participants underwent, on two separate days, a clinical evaluation followed by a needle biopsy of the vastus lateralis muscle.
Clinical and Physiological Evaluation
Anthropometric measurements were obtained followed by pulmonary function testing to assess FEV 1 , residual volume, and diffusing capacity of the lung for carbon monoxide. Patients with COPD and control subjects completed a standard incremental peak exercise test for determination of peak work capacity and aerobic power (peak rate of oxygen consumption) with continuous monitoring of ECG, ventilatory parameters, and arterial oxygen saturation through finger oximetry. The partial pressure of oxygen in arterial blood (Pa O 2 ) at rest and during submaximal exercise was determined from blood samples drawn from the radial artery catheter and analyzed with a Rapidlab 840 (Bayer Healthcare, Tarrytown, NY) blood gas analyzer.
Muscle Needle Biopsy
Percutaneous biopsy samples of the right vastus lateralis muscle were obtained by standard Bergstrom needle technique as previously described (19) . Each sample was immediately put on ice in precooled stabilizing buffer, and transported to the laboratory for immediate dissection and permeabilization.
Preparation of Permeabilized Myofiber and Ghost Fiber Bundles
Dissection and permeabilization of fiber bundles with saponin were performed as described previously (20, 21) . Ghost fibers were prepared as per Saks and coworkers (20) by incubating saponinpermeabilized bundles in a high-KCl medium, which allows extraction of myosin. Permeabilized myofibers and ghost fiber bundles were then kept on ice until use. All mitochondrial parameters were determined at least in duplicate for every subject. See the online supplement for further details on muscle biopsy, preparation of myofibers, and methods to assess the various mitochondrial parameters described in subsequent sections.
Mitochondrial Respiration
Mitochondrial respiratory function of permeabilized myofibers was determined as per Picard and coworkers (14) . Rates of oxygen consumption were expressed as nanomoles of oxygen per minute per milligram dry weight, or per unit of the marker enzyme citrate synthase (CS) to normalize for differences in mitochondrial content between individuals.
Mitochondrial Production of Reactive Oxygen Species
Mitochondrial H 2 O 2 production was measured in permeabilized fiber bundles with the fluorescent probe Amplex red (Invitrogen, Carlsbad, CA) as described previously (14, 22) . Rates of H 2 O 2 production were calculated from a standard curve established under the same experimental conditions except that fibers were absent. All H 2 O 2 measurements were expressed per milligram of dry weight or per unit of CS.
Sensitivity to Ca 21 -induced PTP Opening
Accumulation of Ca 21 in the mitochondrial matrix is the most important and obligatory trigger for PTP opening (23) . Sensitivity to permeability transition is therefore commonly assessed in isolated mitochondria by determining mitochondrial calcium retention capacity (CRC) in response to a Ca 21 challenge (24) . In the present study, a novel method developed in our laboratory was used to determine CRC in ghost fibers (14) . Briefly, mitochondrial Ca 21 uptake after the addition of a single Ca 21 pulse (20 nM) was followed by monitoring the decrease in extramitochondrial calcium concentration, using the fluorescent probe Calcium green-5N (Invitrogen). Progressive uptake of Ca 21 by mitochondria was monitored until mitochondrial Ca 21 release caused by opening of the PTP was observed. The CRC, which is a reliable index of PTP sensitivity (25) , was calculated as total amount of Ca 21 taken up by mitochondria before Ca 21 release. CRC values were expressed per milligram of dry fiber weight and per unit of CS.
Citrate Synthase Assay
The activity of CS in fiber bundles extracts was measured as per Picard and coworkers (14) and reported as milliunits per milligram of dry fiber weight. We and others have previously shown the validity of CS as an indirect marker of mitochondrial volume density in skeletal muscle (14, 26) .
Statistical Analyses
Results are expressed as means 6 SEM. Mean comparisons of baseline physiological characteristics and peak exercise performance between patients and control subjects were achieved through a two-tailed Student t test. Similarly, planned comparisons of CS activity, the rate of oxygen consumption at each stage of respiration, H 2 O 2 production, and CRC were performed by two-tailed Student t test. Significance was assumed at P < 0.05. Table 1 shows the characteristics of the patients with COPD and control subjects. Subjects were of similar age and sex. As per the inclusion criteria, patients showed moderate to severe disease severity (FEV 1 5 1.32 6 0.5 L; 47 6 17% predicted). Patients showed a lower body weight that was related to a lower lean mass and a lower body mass index (BMI) than the control group, although it fell within the normal range (27) . The fat-free mass index was above the threshold of cachexia (less than 17 kg/m 2 ) (28) for all subjects. As expected, patients showed a reduced peak exercise capacity compared with healthy control subjects. None of the patients displayed resting hypoxemia, although exercise-induced hypoxemia was observed (Pa O 2 at 65% peak power: 100 6 9 and 72 6 12% in control and COPD, respectively; P , 0.05).
RESULTS
Study Participant Characteristics
Oxidative Capacity and Respiratory Function
As shown in Figure 1B , respiration per unit of fiber weight was significantly lower in fibers of patients with COPD than in fibers from healthy control subjects under all respiratory states with the exception of the rate of glutamate-malate-driven respiration ( _ VGM) and the rate of TMPD-ascorbate-driven respiration ( _ VTMPD), for which differences did not reach statistical significance. The activity of the mitochondrial marker enzyme CS was 37% lower in fibers from patients with COPD compared with healthy control subjects (52 6 4 vs. 84 6 4 mmol Á min 21 Á mg 21 dry weight; P < 0.0001). As shown in Figure 1C , normalization of respiration rates per unit of CS abolished all differences observed between the two experimental groups. There was no significant difference in the acceptor control ratio, representing the coupling between oxidation and phosphorylation in COPD compared with the control subjects ( _ VADP/ _ VGM, 3.44 6 0.45 vs. 3.38 6 0.64 in control and COPD; P 5 0.67). Similarly, no significant differences were observed between the two experimental groups for the Vsucc/VADP ratio (1.20 6 0.23 vs. 1.04 6 0.08; P 5 0.18) and the maximal capacity of cytochrome c oxidase (COX) to drive oxidative respiration when stimulated directly (COX excess capacity, 5.72 6 0.76 vs. 6.74 6 0.62; P 5 0.37). Figure 2A shows a representative tracing of H 2 O 2 production obtained in permeabilized fibers in response to sequential addition of substrates and inhibitors. In general, net H 2 O 2 release by fibers was low in the absence of respiratory substrates in both groups but increased by approximately twofold after addition of the complex I donors glutamate and malate. However, in line with previous observations (14, 22, 29) , the highest rates of H 2 O 2 release under basal conditions were observed in the presence of the complex II donor succinate. Subsequent addition of ADP at increasing concentrations led to a progressive reduction in H 2 O 2 release, which is expected when electron flow through the respiratory chain is stimulated (29) . Finally, interruption of normal electron flow with addition of the complex III inhibitor antimycin A induced a substantial increase in H 2 O 2 release, as expected.
Production of Reactive Oxygen Species
In comparing patients with COPD with healthy control subjects, the net release of mitochondrial H 2 O 2 per milligram of fiber weight was similar under all states of respiration (data not shown) in spite of a lower mitochondrial volume density in COPD muscle. Therefore, when normalized per unit of CS activity, net H 2 O 2 release was significantly higher in COPD than in control subjects during baseline succinate-driven respiration, and at all rates of ADP-stimulated respiration. H 2 O 2 release also tended (P 5 0.09) to be higher in COPD fibers in the presence of antimycin A, which was used to promote H 2 O 2 release by blocking electron flow at complex III. Figure 3A shows typical Ca 21 kinetics measured in ghost fibers energized with glutamate-malate. In all experiments the addition of exogenous Ca 21 to the incubation medium caused a large increase in Calcium green-5N fluorescence, which was immediately followed by a progressive reduction due to the electrophoretic uptake of Ca 21 by mitochondria. Ca 21 uptake then reached a plateau followed by the release of accumulated Ca 21 . When experiments were repeated in the presence of the PTP inhibitor cyclosporin A (CsA) the amount of Ca 21 required to trigger Ca 21 release (i.e., CRC) was approximately doubled, confirming that opening of the PTP caused this phenomenon. In previous studies we have also shown that the Ca 21 uptake was specific to mitochondria and entirely dependent on the presence of respiratory substrates (14) . As shown in Figure 3B , CRC values per unit of mitochondrial CS were 56% higher in fibers from patients with COPD compared with healthy control subjects (214 6 40 vs. 137 6 31 mmol Ca 21 /mU CS; P 5 0.019), indicating a lower sensitivity to Ca 21 -induced opening of the PTP in COPD muscle.
Sensitivity to Ca 21 -induced PTP Opening
DISCUSSION
To our knowledge, this study provides the first integrative assessment of mitochondrial function in skeletal muscle from patients with moderate to severe COPD. We investigated three primary aspects, namely, mitochondrial respiration, production of reactive oxygen species, and susceptibility to permeability transition pore opening in COPD and a group of healthy, agematched control subjects. Our results indicate that although whole muscle oxidative capacity was reduced in patients with COPD, respiratory properties of individual mitochondria did not differ from those of healthy control subjects. On the other hand, it was found that in COPD, production of reactive oxygen species per mitochondrion was increased and sensitivity to Ca 21 -induced opening of the permeability transition pore was diminished compared with control subjects.
Respiratory Function
Tissue oxidative capacity is determined by the number and size of mitochondria (i.e., mitochondrial volume density), and by the respiratory function of individual mitochondria. In peripheral muscle from patients with COPD, there is clear evidence that oxidative capacity is impaired as a result of a reduction in mitochondrial volume density (assessed by marker enzyme activities or directly with electron microscopy) (16, 30) and expression of key transcription factors for mitochondrial biogenesis (31) . In the present study, the systematic reduction in respiratory rates per milligram of fiber weight in the muscle of patients with COPD is in line with these previous results. Moreover, the activity of the mitochondrial marker enzyme CS was reduced by approximately 40% in COPD muscle, which is comparable to values reported by others (16, 30) .
However, our results indicate that mitochondrial respiration expressed per unit of CS was not significantly different between patients and control subjects irrespective of the respiratory state (basal, ADP stimulated, and uncoupled) and type of substrate oxidized (complex I, II, and III). Reporting mitochondrial respiratory rates per unit of CS constitutes an important feature of this study, by providing the distinct advantage of assessing respiratory function per mitochondrion. To date, this study is the first to report it as such for a group of patients with COPD. The normalization of mitochondrial respiratory rates relative to citrate synthase provides a more valuable index of mitochondrial function than measurements of respiratory chain enzyme activities or respiratory rates relative to muscle mass because it is not confounded by differences in mitochondrial content, which are known to vary significantly according to physical activity levels. The absence of a difference in respiration rates per unit of CS reported in the present study therefore rules out any specific mitochondrial respiratory impairments. This is further supported by the fact that several important respiratory parameters (acceptor control ratio, Vsucc/VADP ratio, and COX excess capacity) were not different in fibers from control subjects and COPD, which would not have been the case if specific impairments had been present.
In general, these data are in agreement with results by Rabinovich and coworkers (32) , who reported no difference in the acceptor control ratio in succinate-energized mitochondria from patients with COPD when BMI was normal (i.e., above 21 kg/m 2 ), although a reduced acceptor control ratio was observed in a subgroup of patients with low BMI (,19 kg/m 2 ). Similarly, increased expression of COX I subunit and COX activity has been reported in patients with COPD with chronic arterial hypoxemia (Pa O 2 , 60 mm Hg) (33) but not in patients with higher Pa O 2 , suggesting that hypoxia induces specific changes at the level of COX to improve its efficiency at low arterial oxygen tensions (34) . In the present study, although patients exhibited exercise-induced arterial oxyhemoglobin desaturation, resting levels of Pa O 2 remained between 62 and 88 mm Hg, with an average value (77.5 mm Hg) considered within the normal range. It may therefore be suggested that transient hypoxemic spells, as may result from brief periods of exerciseinduced arterial oxygen desaturation, may not be sufficient to trigger COX1-related adaptation. Taken together, these results indicate that in patients with COPD who are not hypoxemic at rest, with moderate to severe disease involvement but with normal BMI, mitochondrial function appears to remain intact.
Mitochondrial ROS Production
Oxidative stress in peripheral muscle is increasingly being positioned as a potentially important contributor to muscle dysfunction in COPD (4). Studies have reported increased levels of lipid peroxidation by-products (35, 36) and accumulation of both nitrosylated (35, 37) and carbonylated proteins (38) in the muscle of patients with COPD at rest. Moreover, an abnormal decrease in reduced glutathione content has been reported in response to exercise training in patients with COPD, suggesting that muscle from patients with COPD can produce excessive amounts of ROS when confronted with repetitive metabolic stress (39) . However, several sources of free radicals may be responsible for this phenomenon and the extent to which mitochondria contribute, if at all, is not established.
To our knowledge, the present study is the first to provide direct measurements of mitochondrial H 2 O 2 production in muscle of patients with COPD. We observed that total H 2 O 2 production per unit of fiber weight was similar in the two experimental groups (data not shown). However, when expressed relative to CS activity, net release of H 2 O 2 per mitochondrion was significantly higher in fibers of patients with COPD Figure 3 . Sensitivity to Ca 21 -induced permeability transition pore (PTP) opening in ghost fibers from patients with chronic obstructive pulmonary disease (COPD) and healthy control subjects. (A) Typical changes in [Ca 21 ] in the incubation medium as a result of mitochondrial Ca 21 uptake and release. Experiments were initiated by the addition of ghost fibers (data not shown) followed by a single pulse of 20 nmol of Ca 21 . A progressive reduction in fluorescence was observed as a result of mitochondrial Ca 21 uptake followed by the release of accumulated Ca 21 due to PTP opening. Calcium retention capacity (CRC) represents the amount of Ca 21 taken up by mitochondria before the initiation of Ca 21 release (denoted by thin gray lines). As expected, the PTP inhibitor cyclosporin A (CsA, 1 mM) significantly increases the CRC. Although not shown, the response to CsA was similar in fibers from both experimental groups. (B) Mitochondrial calcium retention capacity in fibers from patients with COPD and healthy control subjects. Results are normalized per unit of the marker enzyme citrate synthase (CS). a Significantly different from control (P , 0.05). compared with those of healthy control subjects. This phenomenon was observed during baseline complex II-driven respiration, which is associated with high rates of superoxide production, and persisted under conditions of active phosphorylation, which is known to reduce superoxide generation (29) . These results thus provide clear evidence that mitochondria from patients with COPD possess properties that potentiate H 2 O 2 production. Of note, this phenomenon, which was observed in vitro with standardized levels of oxygenation, could be expected to be further enhanced in vivo when muscles of patients with COPD experience hypoxia, a condition associated with the promotion of superoxide generation by the respiratory chain (40, 41) .
Factors responsible for the enhanced mitochondrial H 2 O 2 release in COPD muscle currently remain unclear. Defects in respiratory chain complexes are a common cause of oxidative stress in pathologies involving mitochondria, such as ischemiareperfusion (42) . This, however, cannot account for the enhanced ROS release seen in the present study as no specific mitochondrial respiratory dysfunction could be observed. Interestingly, we (14) and others (22) have reported that mitochondria within fast glycolytic type II fibers release significantly greater amounts of H 2 O 2 than their counterparts in slow oxidative type I fibers in rats. This phenomenon is attributed to the fact that mitochondria from type II fibers display a lower H 2 O 2 -scavenging capacity and possibly other intrinsic differences in factors that modulate superoxide production by the respiratory chain (22) . Although it was not possible to quantify fiber type composition in the present study, there is strong agreement that the proportion of type II fibers is increased in COPD (3, (43) (44) (45) (46) (47) . As an example, one study of a COPD population similar to ours reported a 24% decrease in type I fiber proportion (34 vs. 58%) with a concomitant increase in type II fibers in patients with COPD compared with control subjects (45) . Moreover, in our previous animal study (14) we reported that the difference in ROS production between type I and type II fibers was 250%. On the basis of this value, the 63% difference in ROS production observed between patients with COPD and healthy control subjects in the present study would represent a 25% difference in fiber type proportion, which is well within the range of change in fiber type reported for this patient population (3, (43) (44) (45) (46) (47) . Consequently, the higher mitochondrial H 2 O 2 release observed in muscle from patients with COPD in the present study could be reflective of a normal healthy muscle fiber type shift in response to reduced muscle activity and associated sedentary lifestyle, rather than the result of pathological alterations in mitochondrial function.
Susceptibility to Opening of the Permeability Transition Pore
Another key property of mitochondria that is receiving much attention is their capacity to trigger cell death. A key event in this process is the opening of the PTP, a nonspecific proteinaceous channel of the inner mitochondrial membrane (23, (48) (49) (50) (51) (52) (53) (54) . Prolonged opening of the PTP results in mitochondrial swelling, loss of membrane potential (DC), uncoupling of oxidative phosphorylation, ATP hydrolysis, and release of several proapoptotic proteins normally confined to mitochondria including cytochrome c, AIF, Endo-G, Smac/Diablo, and OmiHTrA2.
In view of this central role of the PTP, we determined whether sensitivity to Ca 21 -induced opening of the PTP differed in mitochondria from patients with COPD compared with age-matched healthy control subjects. To our knowledge, PTP regulation has not previously been studied in human skeletal muscle tissue samples, be it from healthy or diseased individuals. Our results show that mitochondria from COPD muscle are significantly more resistant to Ca 21 -induced PTP opening than are those of healthy control subjects. Results from animal studies clearly suggest that mitochondria generally become less, not more, resistant to PTP opening in the presence of myopathic conditions such as denervation (25) , congenital dystrophies such as Duchenne (55) and Bethlem (56, 57) , bupivacaineinduced myotoxicity (58), or aging-induced sarcopenia (59) , all of which have been associated with activation of cell death either by apoptosis or necrosis. Evidence of enhanced apoptosis has been reported in patients with COPD with low BMI (8) but not in patients with a less severe condition (8, 47) , such as the patients in the present study. Our findings are therefore in direct contradiction to the expected myopathic patterns, which may be taken to suggest that at least in moderate to severe COPD, mitochondria are not more prone to permeability transition. It will therefore be of interest in future studies to determine whether vulnerability to PTP opening develops as the disease evolves to a more severe state.
The factors accounting for the greater resistance to Ca 21 -induced PTP opening observed in patients with COPD currently remain unclear. An intriguing possibility may be that, as discussed above for H 2 O 2 release, the observed resistance to PTP opening may also be related to the greater proportion of type II fibers within COPD muscle (3, (43) (44) (45) (46) (47) .
In support of this suggestion is our observation that mitochondria from type II rat fibers are intrinsically more resistant to Ca 21 -induced PTP opening than are mitochondria from type I fibers (14) , as demonstrated by a 300% greater calcium retention capacity per unit of CS. On the basis of this value, the 56% difference in CRC observed between healthy control subjects and patients with COPD in the present study would represent an 18% difference in fiber type proportions, again consistent with previous reports (3, (43) (44) (45) (46) (47) . In the animal study, we argued that a higher Ca 21 threshold for PTP opening in fast fibers could represent a basic cellular mechanism to prevent accidental activation of cell death signaling because fast fibers typically display higher and more frequent Ca 21 surges than slow fibers during contraction.
Perspective
The present study indicates that in patients with moderate to severe COPD, but who do not display aggravating conditions that worsen disease prognosis (such as cachexia or hypoxemia), the reduction in peripheral locomotor muscle oxidative capacity is due to a lower mitochondrial volume density but not to any specific mitochondrial respiratory abnormalities. We propose that the enhanced ROS production and resistance to PTP opening observed in mitochondria from COPD muscle could be related to a greater proportion of type II fibers compared with healthy control subjects. This is supported by observations from animal models showing that mitochondria from fast glycolytic muscle produce more ROS (14, 22) and are more resistant to PTP opening (14) , but yet display similar respiratory function as their counterparts in slow oxidative muscle (14) . Therefore, from the perspective of mitochondrial function integrity, our results do not support the presence of a myopathic state at this stage of disease but rather point to disuse as the main factor underlying mitochondrial alterations within moderate to severe COPD muscle. Future studies are required to determine whether mitochondrial dysfunction develops in patients with more severe disease as a result of aggravating conditions such as hypoxemia, chronic inflammation, and cachexia.
